Predictive Value of Reduced Keratinized Mucosa on the Secondary Prevention of Peri-implant Mucositis and Periimplantitis in Patients Attending Regular Supportive Peri-implant Care. A Longitudinal Analysis
1 other identifier
observational
104
1 country
1
Brief Summary
- Capture of the potential risk factor "lack of band of keratinised mucosa" over a period of up to 5 years.
- Recording of peri-implant inflammatory processes in study participants that are not recorded during normal tooth cleaning
- Registration of the extent of radiographic bone loss. Bone resorption through analysis of existing X-ray images
- Individual therapy recommendation/individual supportive peri-implant care in case of peri-implant inflammation
- The present study was specifically designed to investigate the effect of reduced width of keratinized mucosa (KM) on the secondary prevention of peri-implant mucositis and peri-implantitis in patients attending a supportive peri-implant care program (SPIC) over an observation period of up to five years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2020
CompletedFirst Submitted
Initial submission to the registry
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
April 7, 2023
CompletedApril 7, 2023
March 1, 2023
8 months
March 27, 2023
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Protective value of keratinized mucosa around dental implants in periodontal healthy patients
Keratinized mucosa is a significant protective factor for the progression of peri-implant mucositis to severe peri-implant mucositis and to peri-implantitis in patients without history of periodontitis attending regular SPIC over a period of up to five years.
Up to five years
Secondary Outcomes (1)
Mucositis severity score (MSS) related to the supported peri implant care (SPIC)
Up to five years
Study Arms (3)
General population (i)
All participants of the study, including any periodontal condition.
Periodontally healthy patients with history of periodontitis (ii)
Patients whose current periodontal condition is healthy but who have developed periodontitis in the past.
Periodontally healthy patients without history of periodontitis (iii)
Patients whose current periodontal condition is healthy, who have also not had periodontitis in the past.
Interventions
1. Examination of the inclusion criteria 2. Medical history/patient-specific data (smoking, tumour diseases, radiation, gender, number of implants, history of periodontitis). 3. Recording of implant-specific parameters (measurement depth at six sites per implant(probing depth/PD), bleeding and or pus on probing (BOP) at six measurement sites per implant, condition of the peri-implant mucosa using the modified plaque index(mPI) and the modified ginigiva index (mGI), measurement of the width of the keratinised mucosa(KM), type of denture, approximal plaque index (API), radiographically detectable bone resorption.
Eligibility Criteria
104 patients with at least one root-shaped dental implant who took part in one of the previous studies and who were attending supportive peri-implant care (SPIC) at the Department of Prosthetic Dentistry and Biomedical Materials Science of Hannover Medical School were asked to participate in the study.
You may qualify if:
- \- Patients aged at least 18 years who have at least one root-form dental implant in situ and were part of the first (DOI10.1111/clr.13432) and/or the second (DOI 10.1007/s00784-020-03422-1) observational study
You may not qualify if:
- Systemic antibiotic use up to 3 months before the examination
- pregnancy
- lactating mothers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medizinische Hochschule Hannover (MHH)
Hanover, Lower Saxony, 30625, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2023
First Posted
April 7, 2023
Study Start
February 12, 2020
Primary Completion
October 23, 2020
Study Completion
December 17, 2020
Last Updated
April 7, 2023
Record last verified: 2023-03